WaveMan · Company
DXYN · Dixie Group Inc
> Search tickers & screens ⌘K
LIVE
← All companies

DXYN Dixie (DXYN) Insider Trading, Ownership & Congress Trades

Consumer Goods · Carpets & rugs · CIK 0000029332
Quote by TradingView
Activist 13D
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Revenue growth
-2.9%
XBRL, annual
Net margin
-3.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$253.9M
four quarters, 2025-06-29 to 2026-06-27
History
FY Dec 2025$257.4M
FY Dec 2024$265.0M
FY Dec 2023$276.3M
FY Dec 2022$303.6M
FY Dec 2021n/a
Jun 2026$68.6M
Mar 2026$59.4M
Dec 2025$63.5M
Sep 2025$62.4M
Jun 2025$68.6M
Mar 2025$63.0M
Dec 2024$64.4M
Sep 2024$64.9M
At each fiscal year end
Single quarter
Net margin, TTM
-1.9%
net income over revenue, 2025-06-29 to 2026-06-27
History
FY Dec 2025-3.0%
FY Dec 2024-4.9%
FY Dec 2023-1.0%
FY Dec 2022-11.6%
FY Dec 2021n/a
Jun 2026+1.6%
Mar 2026+1.9%
Dec 2025-4.7%
Sep 2025-6.5%
Jun 2025+1.7%
Mar 2025-2.7%
Dec 2024-11.2%
Sep 2024-6.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$7.6M
operating cash flow minus capex, 2020-09-27 to 2021-09-25
History
FY Dec 2025$7.6M
FY Dec 2024$6.1M
FY Dec 2023$7.2M
FY Dec 2022$3.6M
FY Dec 2021$3.8M
Jun 2026n/a
Mar 2026n/a
Dec 2025n/a
Sep 2025n/a
Jun 2025n/a
Mar 2025n/a
Dec 2024n/a
Sep 2024n/a
At each fiscal year end
Single quarter
Debt to equity
2.46x
long-term 2026-06-27 plus current 2021-12-25 (54 months older than the period end); equity 2026-06-27
History
FY Dec 20253.23x
FY Dec 20241.97x
FY Dec 20232.79x
FY Dec 20223.11x
FY Dec 20211.16x
Jun 20262.46x
Mar 20262.80x
Dec 20253.23x
Sep 20252.46x
Jun 20251.87x
Mar 20252.06x
Dec 20241.97x
Sep 20243.74x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.30x
TTM operating cash flow over long-term 2026-06-27 plus current 2021-12-25 (54 months older than the period end)
History
FY Dec 20250.29x
FY Dec 20240.26x
FY Dec 20230.10x
FY Dec 20220.08x
FY Dec 20210.11x
Jun 20260.30x
Mar 20260.29x
Dec 20250.29x
Sep 20250.28x
Jun 20250.28x
Mar 20250.27x
Dec 20240.26x
Sep 20240.09x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-36.0%
TTM net income over average of 2025-06-28 and 2026-06-27
History
FY Dec 2025-60.9%
FY Dec 2024-57.1%
FY Dec 2023-8.9%
FY Dec 2022-71.7%
FY Dec 2021+2.5%
Jun 2026-36.0%
Mar 2026-38.8%
Dec 2025-60.9%
Sep 2025-67.4%
Jun 2025-54.0%
Mar 2025-58.8%
Dec 2024-57.1%
Sep 2024-10.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-2.6%
TTM net income over average of 2025-06-28 and 2026-06-27
History
FY Dec 2025-4.3%
FY Dec 2024-7.1%
FY Dec 2023-1.4%
FY Dec 2022-16.0%
FY Dec 2021+0.7%
Jun 2026-2.6%
Mar 2026-2.6%
Dec 2025-4.3%
Sep 2025-6.2%
Jun 2025-6.0%
Mar 2025-6.3%
Dec 2024-7.1%
Sep 2024-1.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
History
FY Dec 2025n/a
FY Dec 2024n/a
FY Dec 2023n/a
FY Dec 2022n/a
FY Dec 2021+6.9%
Jun 2026n/a
Mar 2026n/a
Dec 2025n/a
Sep 2025n/a
Jun 2025n/a
Mar 2025n/a
Dec 2024n/a
Sep 2024n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+4.1%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
History
FY Dec 2025+0.1%
FY Dec 2024-4.9%
FY Dec 2023+3.2%
FY Dec 2022-16.4%
FY Dec 2021+5.6%
Jun 2026+4.1%
Mar 2026+4.4%
Dec 2025+0.1%
Sep 2025-3.5%
Jun 2025-3.5%
Mar 2025-4.3%
Dec 2024-4.9%
Sep 2024+3.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
History
FY Dec 2025n/a
FY Dec 2024n/a
FY Dec 2023n/a
FY Dec 2022n/a
FY Dec 202180.43x
Jun 2026n/a
Mar 2026n/a
Dec 2025n/a
Sep 2025n/a
Jun 2025n/a
Mar 2025n/a
Dec 2024n/a
Sep 2024n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
History
FY Dec 2025n/a
FY Dec 2024n/a
FY Dec 2023n/a
FY Dec 2022n/a
FY Dec 2021n/a
Jun 2026n/a
Mar 2026n/a
Dec 2025n/a
Sep 2025n/a
Jun 2025n/a
Mar 2025n/a
Dec 2024n/a
Sep 2024n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
History
FY Dec 2025n/a
FY Dec 2024n/a
FY Dec 2023n/a
FY Dec 2022n/a
FY Dec 2021n/a
Jun 2026n/a
Mar 2026n/a
Dec 2025n/a
Sep 2025n/a
Jun 2025n/a
Mar 2025n/a
Dec 2024n/a
Sep 2024n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
History
FY Dec 2025n/a
FY Dec 2024n/a
FY Dec 2023n/a
FY Dec 2022n/a
FY Dec 2021n/a
Jun 2026n/a
Mar 2026n/a
Dec 2025n/a
Sep 2025n/a
Jun 2025n/a
Mar 2025n/a
Dec 2024n/a
Sep 2024n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-09. Hover a figure to see how it was computed.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.

DXYN Stock Sonar score 4/7 axes

Find similar shapesCompare

DXYN ranks highest on risk and compliance (84th percentile) and growth (33rd), and lowest on financial health (28th), among Consumer Goods peers.

Profitability
32
Inputs
  • Return on equity-36.0% · 14 pct, sector of 105
  • Return on assets-2.6% · 36 pct, sector of 125
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed+4.1% · 46 pct, sector of 109
Financial health
28
Inputs
  • Debt to equity2.46x · 5 pct, sector of 112
  • Cash flow to debt0.30x · 50 pct, sector of 97
Growth
33
Inputs
  • Revenue growth, YoY-2.9% · 33 pct, sector of 146
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
84
Inputs
  • Short interest, % of float+0.1% · 94 pct, sector of 159
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
  • New text in Risk Factors, latest 10-K+11.6% · 58 pct, sector of 111
3 not measured: Insider conviction, Institutional and government, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

What the filings say about DXYN

1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 7.3% of the class. Each figure is counted from SEC and House filings as of 2026-10-12, dated the day the filing was made public.

Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no Congress trades reported
Funds
under five funds report holding it
Revenue
-2.9% year over year
below 67% of Consumer Goods
Margin
-3.0% net margin
below 63% of Consumer Goods
Buybacks
$14.0K repurchased, FY to 2026-06-27
below 99% of Consumer Goods
Short interest
0.1% of the float short (float per yahoo 2026-10-09) · 1.0 days to cover · settled 2026-09-30
The situation: each line is one rule over one dataset
Daniel K Frierson disclosed a 5%+ stake (7.3%) in the last six months.
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch DXYN

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-48.5%12M
-59%-40%-20%+0%2025-102025-122026-022026-042026-062026-082026-10 2026-05-26 · Daniel K Frierson filed a 5%+ stake (7.3%)2026-05-26 · Joan H. Frierson, individually in her capacity as trustee for named grandchildren filed a 5%+ stake (1.0%)2026-05-26 · Emily F. Brown filed a 5%+ stake2026-05-26 · D. Kennedy Frierson, Jr. filed a 5%+ stake (3.1%)
13D/G stake
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
ELFFNKOPTONPGVTSIECLATERELMHKCHDCALLEVI

Dixie insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for DIXIE GROUP INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-12.

Insider
Filed
Shares
Value
KLINE LOWRY F
Director
BUY
2022-11-16
10,000
$10.0K
Context
  • First open-market trade here by this insider on our record.
  • The trade is 10.6% of the 94,699 shares held after it.
  • No other insider bought within 30 days.
  • No fund added in the 13F quarter to Jun 30, 2026.
Insider activity: Director KLINE LOWRY F bought about $10.0K of DXYN on the open market on Nov 16, 2022, the largest insider purchase at the company on our record.
1 transaction on record · a thin record, read with care
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.

Who owns DXYN: institutional holders (13F)

13F holdings, latest reported quarter
HUNTINGTON NATIONAL BANK
1 sh
$0

Congress trades in DXYN

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
Daniel K Frierson
Activist 13D · 2026-05-26
7.3%
Joan H. Frierson, individually in her capacity as trustee for named grandchildren
Activist 13D · 2026-05-26
1.0%
Emily F. Brown
Activist 13D · 2026-05-26
0.0%
D. Kennedy Frierson, Jr.
Activist 13D · 2026-05-26
3.1%

DXYN planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Daniel K. Frierson
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$911.6K
$880.5K
$489.5K
-38%
n/a
2024
$707.6K
$699.8K
$394.2K
-88%
n/a
2023
$1.2M
$1.1M
$628.4K
-71%
n/a
2022
$976.1K
$271.4K
$498.4K
-70%
n/a
2021
$1.5M
$1.7M
$690.6K
+116%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$257.4M$265.0M$276.3M$303.6M
Gross profit$69.5M$65.5M$73.9M$53.6M
Operating income$118.0K$-5.9M$5.0M$-28.2M
Net income$-7.6M$-13.0M$-2.7M$-35.1M
EPS (diluted)-0.52-0.88-0.18-2.32
Cash$3.2M$19.0Kn/an/a
Long-term debt$25.1M$28.5M$78.3M$94.7M
Buybacks$27.0K$585.0K$43.0K$737.0K
SEC XBRL, fiscal years, as known on 2026-10-12

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies